May 22, 2022 / 10:00PM GMT
Operator
Thank you for standing by, and welcome to the AFT Pharmaceuticals 2022 Full Year Results Analyst Briefing. (Operator Instructions)
I would now like to hand the conference over to Dr. Hartley Atkinson, CEO. Please go ahead.
Hartley Atkinson - AFT Pharmaceuticals Limited - Co-Founder, CEO, MD & Executive Director
Yes. Thanks, Noah. Thanks, everyone, and welcome. So basically, what we'll do is go through the presentation, which I assume you should have. As the cover page says, it's the -- it's May 2022, and we're going through our last year financial results ended 31st March 2022. So that's Page 1.
Page 2 is effectively the small print, which I assume you will have read and just take that as read, thank you.
So now Page 3 to start to go into the details. So basically, what we're showing on this slide is the sales growth has continued. Basically, as you can see from that graph on the bottom right, we're growing at about 14.4% CAGR over the last 10 years, which would roughly double our sales in just over every 5 years. And that's
Full Year 2022 AFT Pharmaceuticals Ltd Earnings Call Transcript
Mar 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers